Source: International Congress 2016 – ERS publications: a focus on recent guidelines and task forces
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Haileyesus Getahun (Geneva, Switzerland). Management of latent Mycobacterium tuberculosis infection: WHO guidelines for countries with a low tuberculosis burden. International Congress 2016 – ERS publications: a focus on recent guidelines and task forces

Member's Comments

No comment yet.

Related content which might interest you: The dynamics of tuberculosis incidence and diagnostics of latent tuberculosis tuberculosis infection in children of Ukraine. Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people Year: 2018 Annual risk of infection with Mycobacterium tuberculosis Source: Eur Respir J 2005; 25: 181-185 Year: 2005 Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012 Prevention of TB in areas of low incidence Source: Eur Respir Mon 2012; 58: 72-83 Year: 2012 Treatment of latent infection with Mycobacterium tuberculosis: update 2010 Source: Eur Respir J 2011; 37: 690-711 Year: 2011 Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2 Year: 2014 Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands Source: Eur Respir J 2016; 48: 1420-1428 Year: 2016 Primary drug resistance against mycobacterium tuberculosis in a high burden country Source: Eur Respir J 2006; 28: Suppl. 50, 587s Year: 2006 TB in migrants Source: Eur Respir Mon 2012; 58: 194-205 Year: 2012 Active case-finding of tuberculosis in Europe Source: Annual Congress 2007 - Clinical epidemiology of tuberculosis Year: 2007 Drug resistance profiles of mycobacterium tuberculosis isolates in MDR pulmonary tuberculosis from a high burden developing country Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008 Clinical management of tuberculosis and HIV-1 co-infection Source: Eur Respir J 2010; 36: 1460-1481 Year: 2010 Monitoring latent tuberculosis infection diagnosis and management in the Netherlands Source: Eur Respir J 2016; 47:1492-1501 Year: 2016 Active tuberculosis cases in migrants in Newham: should we extend screening criteria for latent tuberculosis infection Source: International Congress 2017 – Migrants and screening Year: 2017 Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Childhood tuberculosis: progress requires an advocacy strategy now Source: Eur Respir J 2012; 40: 294-297 Year: 2012 Screening for latent tuberculosis infection among healthcare workers in Bulgaria Source: Annual Congress 2009 - Tuberculosis contact screening Year: 2009 The definition of tuberculosis infection based on the spectrum of tuberculosis disease Source: Breathe, 17 (3) 210079; 10.1183/20734735.0079-2021 Year: 2021 The cases of active tuberculosis among persons with latent tuberculosis infection residing in the disease hot spots Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016